Support Office. This structural control is further underscored by the fact that Samsung Biologics' top HR executive is a former Samsung Electronics official. President Park emphasized, "Even if the working-level negotiators attempt to reach a...
companies will be invaluable.” “Convergent has a world-class leadership team and has built one of the most compelling platforms in prostate cancer with an approach that harnesses antibodies as precision delivery vehicles for Ac-225 and could...
options to personalize treatment plans for each patient." "As the leader in hematology, we have a proud history of transforming the treatment landscape for multiple myeloma. This approval represents another pivotal milestone in improving outcomes...
is launching a U.S.-based Clinical Research Program designed to generate clinical evidence supporting product safety, performance, and patient outcomes across global markets. Calaway brings more than 17 years of experience in clinical operations,...
efforts ahead of anticipated market entry in 2027. The Series C will also support advancement of the Spectris platform into additional neurodegenerative indications through their network of brain health collaboratories beginning with WVU...
cases, infantile hemangiomas can lead to serious complications including loss of vision, trouble breathing, or physical deformities, and require intervention with systemic therapy. Treatment with HEMANGEOL is typically initiated between ages five...
year of policy debate. They mark a structural shift where employer governance and market pressure converge to force reform. US-Rx Care advises plan sponsors that they can no longer rely on traditional PBM contracting models and must proactively...
at an advanced stage. About Merck’s research in genitourinary cancers Merck is advancing research aimed at helping transform the treatment landscape and broaden options for people with genitourinary (GU) cancers, including bladder, kidney and...
against novel targets in cancer and other immune-related diseases. Powered by its proprietary 3T-TRACE™ discovery platform, the company integrates high-diversity experimental libraries with advanced machine learning to systematically identify...
diseases, is pleased to announce that the first participant has been dosed in Regimen I of the HEALEY ALS Platform Trial evaluating Neurizon's lead candidate, NUZ-001, for the treatment of amyotrophic lateral sclerosis (ALS). HEALEY ALS Platform...
as Active Chairman of the Board of Directors. Mr. Mayron's appointment follows shareholder approval and submission of his formal Director Eligibility Declaration in accordance with the Israeli Companies Law. Extensive Leadership and Industry...
antibodies in humans. The model allows scientists to rank different antibody candidates by how they are likely to perform, measure how effectively they target specific immune cells, and evaluate their potential to slow disease progression. This...
several assays using capillary blood microsamples, which are collected using the Tasso device, and will serve as the performing laboratory of the combined service. The new partnership with Tasso is an additional element of ARUP's robust offerings...
developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen) platform, today announced the launch of BioFlex, a ready-to-print rhCollagen-based kit designed for Digital Light Processing (DLP) 3D...
enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants. New releases in Bruker ProteoScape™, OmniScape™, and GlycoScape™ software now support...
The most recent data released from the Co-PSMA study clearly establishes that 64Cu-SAR-bisPSMA considerably outperforms its competitors in detecting prostate cancer recurrence and sheds light on the importance of the improved lesion detection,...
PureTech Health plc a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, announced that the U.S. Food and Drug Administration (FDA) and European Commission have granted Orphan Drug...
& Decision Modelling, who will lead evidence synthesis, advanced statistical analysis, and economic modelling that inform market access and Health Technology Appraisal (HTA) decision making within the Access Consulting and Health Economics and...
studies. This is a significant finding for patients, as it offers a potentially reliable strategy for providers and transformative opportunity for patients to manage their IBD journey even when treatment is interrupted.” “In clinical practice,...
factory for drug discovery programs, integrating a chemical compound repository with a high-throughput screening (HTS) platform. Its mission is to act as a bridge between academic research and pharmaceutical development, with a particular focus on...
